Sex differences in the case-fatality rates for COVID-19-A comparison of the age-related differences and consistency over seven countries.
Reads0
Chats0
TLDR
In this paper, the authors examined the magnitude and consistency of the sex differences in age-specific case-fatality rates (CFRs) in seven countries, including Denmark, England, Israel, Italy, Spain, Canada and Mexico.Abstract:
BACKGROUND: Early in the COVID-19 pandemic, it was noted that males seemed to have higher case-fatality rates than females. We examined the magnitude and consistency of the sex differences in age-specific case-fatality rates (CFRs) in seven countries. METHODS: Data on the cases and deaths from COVID-19, by sex and age group, were extracted from the national official agencies from Denmark, England, Israel, Italy, Spain, Canada and Mexico. Age-specific CFRs were computed for males and females separately. The ratio of the male to female CFRs were computed and meta-analytic methods were used to obtained pooled estimates of the male to female ratio of the CFRs over the seven countries, for all age-groups. Meta-regression and sensitivity analysis were conducted to evaluate the age and country contribution to differences. RESULTS: The CFRs were consistently higher in males at all ages. The pooled M:F CFR ratios were 1.71, 1.88, 2.11, 2.11, 1.84, 1.78 and 1.49, for ages 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80+ respectively. In meta-regression, age group and country were associated with the heterogeneity in the CFR ratios. CONCLUSIONS: The sex differences in the age-specific CFRs are intriguing. Sex differences in the incidence and mortality have been found in many infectious diseases. For COVID-19, factors such as sex differences in the prevalence of underlying diseases may play a part in the CFR differences. However, the consistently greater case-fatality rates in males at all ages suggests that sex-related factors impact on the natural history of the disease. This could provide important clues as to the mechanisms underlying the severity of COVID-19 in some patients.read more
Citations
More filters
Journal ArticleDOI
Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine
TL;DR: The consistent excess in adverse events among females for the mRNA COVID-19 vaccine indicates the need to assess and report vaccine adverse events by gender and should be taken into account when determining dosing schedules.
Journal ArticleDOI
Case fatality and mortality rates, socio‐demographic profile, and clinical features of COVID‐19 in the elderly population: A population‐based registry study in Iran
TL;DR: Advanced treatment supports and interventions are needed to reduce mortality rates of COVID‐19 in the elderly population of East Azerbaijan Province because male sex, advanced age, marital status, and living alone were associated with an increased risk of CO VID‐19 fatality.
Journal ArticleDOI
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.
Ana M. B. Menezes,Cesar G. Victora,Fernando Pires Hartwig,Mariângela Freitas da Silveira,Bernardo L. Horta,Aluísio J D Barros,Marilia Arndt Mesenburg,Fernando C. Wehrmeister,Lucia Campos Pellanda,Odir Antônio Dellagostin,Claudio J. Struchiner,Marcelo Nascimento Burattini,Fernando C. Barros,Pedro C. Hallal +13 more
TL;DR: In this article, the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristics.
Journal ArticleDOI
Epidemiology of 4963 deaths associated with COVID‐19 during three pandemic waves in a Latin American city with a high mortality rate, 2020–2021
TL;DR: The characteristics of COVID-19-associated deaths in Barranquilla, Colombia, a city with a high mortality rate, and their changes between pandemic waves are described in this paper .
Journal ArticleDOI
Study of Post-COVID-19 Syndrome in Saudi Arabia.
Manal H Mahmoud,Fahad A Alghamdi,Ghaida A Alghamdi,Loai A Alkhotani,Mohammad A Alrehaili,Dalia K El-Deeb +5 more
TL;DR: A cross-sectional study was conducted from May 2021 through June 2021 using an online structured pre-coded closed-ended, pilot-tested questionnaire in Arabic as mentioned in this paper, which included male and female inhabitants of Saudi Arabia aged 18 years and above with a past history of COVID-19 infection.
References
More filters
Journal ArticleDOI
Meta-Analysis in Clinical Trials*
TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
Journal ArticleDOI
Sex differences in immune responses
Sabra L. Klein,Katie L. Flanagan +1 more
TL;DR: It is emphasized that sex is a biological variable that should be considered in immunological studies and contribute to variations in the incidence of autoimmune diseases and malignancies, susceptibility to infectious diseases and responses to vaccines in males and females.
Journal ArticleDOI
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.
Zhaohai Zheng,Fang Peng,Buyun Xu,Jingjing Zhao,Huahua Liu,Jiahao Peng,Qingsong Li,Chongfu Jiang,Yan Zhou,Shuqing Liu,Chunji Ye,Peng Zhang,Yangbo Xing,Hangyuan Guo,Weiliang Tang +14 more
TL;DR: Clinical manifestations such as fever, shortness of breath or dyspnea were associated with the progression of disease, and laboratory examination such as aspartate amino transferase(AST) > 40U/L, creatinine(Cr) ≥ 133mol/l, hypersensitive cardiac troponin I(hs-cTnI) > 28pg/mL, procalcitonin(PCT) > 0.5mg/L predicted the deterioration of disease.
Journal ArticleDOI
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.
Xiaochen Li,Xiaochen Li,Shuyun Xu,Shuyun Xu,Muqing Yu,Muqing Yu,Ke Wang,Ke Wang,Yu Tao,Yu Tao,Ying Zhou,Ying Zhou,Jing Shi,Jing Shi,Min Zhou,Min Zhou,Bo Wu,Zhenyu Yang,Zhenyu Yang,Cong Zhang,Cong Zhang,Junqing Yue,Junqing Yue,Zhiguo Zhang,Harald Renz,Xiansheng Liu,Xiansheng Liu,Jungang Xie,Jungang Xie,Min Xie,Min Xie,Jianping Zhao,Jianping Zhao +32 more
TL;DR: Survival analysis revealed that male, elder age, leukocytosis, high LDH level, cardiac injury, hyperglycemia, and high-dose corticosteroid use were associated with death in patients with severe COVID-19.
Journal ArticleDOI
Molecular immune pathogenesis and diagnosis of COVID-19.
Xiaowei Li,Xiaowei Li,Manman Geng,Manman Geng,Yizhao Peng,Yizhao Peng,Liesu Meng,Liesu Meng,Shemin Lu,Shemin Lu +9 more
TL;DR: A brief introduction of the general features of SARS-CoV-2 is provided and current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 is discussed, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS/MERS/CoV infection.